glp 1 and anorexia Neurobiological Mechanisms Therapeutic Potential of Glucagon-like Peptide-1 Receptor Agonists in Binge Eating Disorder: A Narrative Review A new NPR article features

2018;11:e201700169

1 As effectiveness of newer dosage forms continues to build, awareness of these drugs rises further (driven by awareness building campaigns) and lower out of pocket costs drive price elasticity, 2 our estimates suggest 1 in 2 eligible adults may adopt a GLP-1 drug over the next 10 year

longum BL21 is associated with gut microbiota changes in a rat model of chronic kidney disease

We set realistic expectations up front and measure against your own baseline rather than a promised result

Research mapping IGF-1 receptor binding describes IGF-1R activation after IGF-I and IGF-II binding, with signalling relevance in cell growth, survival and migration models

Journal of immunological sciences , 3 (4)